-
Silence Therapeutics (NASDAQ:SLN) Receives "Outperform" Rating from William Blair
Source: Buzz FX / 19 Nov 2024 12:16:08 America/New_York
Silence Therapeutics (NASDAQ:SLN) Receives "Outperform" Rating from William Blair Written by MarketBeat November 19, 2024 Share Link copied to clipboard. Silence Therapeutics ( NASDAQ:SLN - Get Free Report ) 's stock had its "outperform" ra
Read more...